Sugar Amino Acids Show Promise in Developing Therapeutic Cyclic Peptides

Strategic Insights -

Researchers at Zhejiang Science Technical University have made significant breakthroughs in the field of cyclic peptides, leveraging the unique properties of sugar amino acids (SAAs) to design and develop next-generation therapeutics. Investigating the structural and functional advantages of SAAs, the team discovered that these hybrid molecules can overcome the limitations of peptide-based treatments, such as proteolytic instability and conformational ambiguity.

Key Takeaways:

  • Sugar amino acids (SAAs) are a class of molecular chimeras that combine the structural rigidity of carbohydrates with the functional display of amino acids.
  • SAAs have garnered attention as programmable conformational constraints, offering a powerful strategy to overcome the limitations of peptide-based therapeutics.
  • The strategic incorporation of SAAs into peptide backbones allows for the rational design of peptidomimetics with pre-organized secondary structures, enhanced metabolic stability, and improved physicochemical properties.
  • Modern, stereoselective strategies have been developed to access the diverse structural landscape of SAAs, yielding versatile building blocks for peptide chemistry.
  • SAAs have been found to induce and stabilize specific secondary structures, such as beta- and gamma-turns, and have exhibited profound abilities to combine conformational control with tunable hydrophilicity.
  • The application of SAA-containing cyclic peptides as therapeutic agents has shown promise, with a detailed case study on gramicidin S analogs underscoring the power of SAAs in elucidating complex structure-activity relationships.

Statistics:

  • The study was funded by the Key Research and Development Program of Zhejiang Province and the Shaoxing science and technology plan project.
  • The research was published in the journal Processes, Volume 13, Issue 9, 2025, Page 2849.
  • The study emphasized the transformative potential of computational design, artificial intelligence, and advanced bioconjugation techniques to accelerate the development of next-generation SAA-based therapeutics.

Sources:

  • Wang, D., et al. "Synthetic Methods of Sugar Amino Acids and Their Application In the Development of Cyclic Peptide Therapeutics." Processes, vol. 13, no. 9, 2025, pp. 2849.
  • Zhejiang Science Technical University, College of Life Sciences and Medicine, Hangzhou 310018, Zhejiang, People's Republic of China
  • NewsRx. Study Findings from Zhejiang Science Technical University Broaden Understanding of Technology (Synthetic Methods of Sugar Amino Acids and Their Application In the Development of Cyclic Peptide Therapeutics). Life Science Weekly. October 21, 2025; p 7790.